Actualización de negociación de medio año
Millimagenes
€25.52
16:30 01/09/22
Para su publicación inmediata | 4 de abril de 2024 |
Gooch y Housego PLC
("G&H" o la "Sociedad" o el "Grupo")
Actualización de negociación de medio año
"Negociación en línea con las expectativas de la gerencia"
Gooch & Housego PLC (AIM: GHH), the specialist manufacturer of photonic components and systems, provides an update on trading for the six months ended 31 March 2024.
Plataforma de
As previously reported, in the first half of the financial year the Group has seen some customers in its industrial and medical laser markets normalise their inventory holdings resulting in lower levels of demand for some of the Group's products. This period of destocking is expected to come to an end towards the end of this calendar year and the Group's revenue from these end markets will then return to growth. In other parts of the Group, most notably our medical diagnostic business and our fibre optic businesses, which supply the semiconductor infrastructure markets, revenue has grown compared with the comparator period.
Revenue for the six month period is expected to be circa £67.5 million (31 March 2023: £71.3 million) supported by the two acquisitions completed in the previous financial year. As previously reported, we expect trading in the current financial year to be more heavily weighted towards the second half than in FY2023.
New orders for the Group's products from our semiconductor, sub-sea data cable and aerospace navigation markets have been strong. We have secured an important new customer for a new fibre optic amplifier module as well as strong orders for our medical diagnostic products. Requests for quotations for our optical systems solutions for armoured vehicles are strong and we expect to convert a number of these into firm orders in the second half of the year.
At 31 March 2024 the Group's order book stood at £115.8 million (31 March 2023: £124.4 million), a decrease of 6.9%, but an increase of 3.6% on an organic constant currency basis, compared with the same time last year. The order book has grown by 2.3% compared with its level at 30 September 2023 on an organic, constant currency basis This order book provides good coverage for our expected second half revenues.
We remain in a strong financial position with a robust balance sheet and significant levels of available funding to support the Group's further growth. At the half year net debt was circa £32 million (March 2023: £19.2 million and September 2023: £31.7 million) and the Group had $35.7 million available from existing committed and uncommitted debt facilities to fund its future growth activities.
We expect trading for the full year to be in line with management's previous expectations.
Progreso estratégico
The Group is making good progress in delivering the strategic plan announced last year. The divestment of our EM4 business completed in March 2024 allows the Group to focus its resources on those parts of its A&D portfolio where it can differentiate itself and achieve acceptable returns.
The transfer of carefully selected product lines to contract manufacturing partners in lower cost regions is accelerating. Fused fibre couplers are now being produced in volume by two outsourced partners and the share of the Group's volumes for this product line being outsourced will now increase with further product lines identified to be transferred.
The Group's new medical diagnostic design, development and production facility based in our Rochester site has been opened. We were pleased to be joined by one of our significant life science customers for the official opening ceremony as this new facility will be serving their North American market requirements. We expect further material orders for our expanded US Life Sciences centre of excellence in the second half of this financial year.
The Group will announce its interim results for the six months ended 31 March 2024 on 4 June 2024.
Charlie Peppiatt, director ejecutivo de Gooch & Housego, comentó:
"Despite the lower volumes in the first half of the financial year resulting from a prolonged period of inventory adjustment by some of our customers we have continued to focus on the delivery of our strategic objectives. In line with our commitment to become a more customer focused business, we have further improved our operational performance reducing our overdue backlog and lead times.
"Our investment in new technologies and products is recognised by our customers and we have secured important new contract wins in the period. Following the strategic addition of the GS Optics and Artemis Optical businesses in FY2023, we have already been rewarded with new customer orders as a result of the Group's enhanced portfolio.
"The divestment of our EM4 business in March this year represented an important milestone on our journey to focus our A&D business on those areas where we can secure acceptable returns, supporting the Group's path to mid-teens profitability."
Para más información, póngase en contacto con:
Charlie Peppiatt, director ejecutivo Chris Jewell, director financiero | Gooch y Housego PLC | +44 (0) 1460 256440 |
| ||
Mark Court / Sophie Wills / Abigail Gilchrist | Buchanan | +44 0 20 7466 5000 |
| ||
Christopher Baird/David Anderson | Banco Investec plc | +44 0 20 7597 5970 |
Notas para los editores
1. Gooch & Housego es una empresa de tecnología fotónica con sede en Ilminster, Somerset, Reino Unido, con operaciones en EE. UU. y Europa. Líder mundial en su campo, la empresa investiga, diseña, crea y fabrica sistemas fotónicos avanzados, componentes e instrumentación para aplicaciones en los sectores aeroespacial y de defensa, industrial, ciencias de la vida e investigación científica. La experiencia en diseño, desarrollo y fabricación líder en el mundo se ofrece a través de una amplia gama de tecnologías complementarias.
2. Toda la información financiera incluida en este anuncio proviene de cuentas de administración no auditadas y excluye cualquier elemento específico. Este anuncio contiene ciertas declaraciones prospectivas que se basan en las expectativas o creencias actuales de la gerencia, así como en suposiciones sobre eventos futuros. Estos están sujetos a factores de riesgo asociados, entre otras cosas, con las circunstancias económicas y comerciales que ocurren ocasionalmente en los países y sectores en los que G&H opera. Se cree que las expectativas reflejadas en estas declaraciones son razonables, pero pueden verse afectadas por una amplia gama de variables que podrían causar que los resultados reales, y los planes y objetivos de G&H, difieran materialmente de los actualmente anticipados o implícitos en las declaraciones prospectivas. . Los inversores no deben depositar una confianza indebida en dichas declaraciones. Nada en este anuncio debe interpretarse como una previsión de beneficios.
RNS puede usar su dirección IP para confirmar el cumplimiento de los términos y condiciones, para analizar cómo interactúa con la información contenida en esta comunicación y para compartir dicho análisis de forma anónima con otros como parte de nuestros servicios comerciales. Para obtener más información sobre cómo RNS y la Bolsa de Valores de Londres utilizan los datos personales que nos proporciona, consulte nuestra Política de privacidad.